Tursi Patrick James's most recent trade in MetaVia Inc. was a trade of 28,147 Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MetaVia Inc. | James Patrick Tursi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 28,147 | 37,219 (0%) | 0% | 0 | Common Stock | |
| MetaVia Inc. | James Patrick Tursi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 5,051 | 9,072 (0%) | 0% | 0 | Common Stock | |
| MetaVia Inc. | Tursi Patrick James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| MetaVia Inc. | James Patrick Tursi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 7,157 | 32,157 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | James Patrick Tursi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 807 | 807 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | James Patrick Tursi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 670 | 2,066 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | James Patrick Tursi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 29,905 | 29,905 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | James Patrick Tursi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 24,510 | 55,852 (0%) | 0% | 0 | Common Stock |